abstract |
Attenuated verotoxin in which at least one of amino acids 167 to 172 and 202 to 207 from the N-terminal of the amino acid sequence of verotoxin A subunit is mutated, the A subunit of the attenuated verotoxin, its A sub Complex of unit and ligand, anticancer agent using them, cancer treatment method, gene encoding the attenuated verotoxin or its A subunit, gene therapy agent using the same, and gene therapy method |